132 related articles for article (PubMed ID: 14628891)
1. Radioimmunodiagnosis of lymph node metastases in head and neck cancer.
de Bree R; Roos JC; Verel I; van Dongen GA; Snow GB
Oral Dis; 2003 Sep; 9(5):241-8. PubMed ID: 14628891
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
3. Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.
de Bree R; Roos JC; Quak JJ; den Hollander W; van den Brekel MW; van der Wal JE; Tobi H; Snow GB; van Dongen GA
J Nucl Med; 1994 May; 35(5):775-83. PubMed ID: 8176458
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
[TBL] [Abstract][Full Text] [Related]
5. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
6. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy of squamous cell carcinoma in the head and neck region.
Heissler E; Grünert B; Barzen G; Fritsche L; Hell B; Felix R; Bier J
Int J Oral Maxillofac Surg; 1994 Jun; 23(3):149-52. PubMed ID: 7930767
[TBL] [Abstract][Full Text] [Related]
9. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Adams S; Baum RP; Stuckensen T; Bitter K; Hör G
Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374
[TBL] [Abstract][Full Text] [Related]
11. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Stokkel MP; ten Broek FW; van Rijk PP
Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
[TBL] [Abstract][Full Text] [Related]
12. [Clinical application of positron-emission tomography for the identification of cervical nodal metastases of head and neck cancer compared with CT or MRI and clinical palpation].
Chen ZW; Zhu LJ; Hou QY; Wang QP; Jiang S; Feng H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):705-8. PubMed ID: 19134342
[TBL] [Abstract][Full Text] [Related]
13. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
14. The value of CT, MRI, and PET-CT in detecting retropharyngeal lymph node metastasis of head and neck squamous cell carcinoma.
Kim JH; Choi KY; Lee SH; Lee DJ; Park BJ; Yoon DY; Rho YS
BMC Med Imaging; 2020 Jul; 20(1):88. PubMed ID: 32727384
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Brouwer J; de Bree R; Comans EF; Castelijns JA; Hoekstra OS; Leemans CR
Eur Arch Otorhinolaryngol; 2004 Oct; 261(9):479-83. PubMed ID: 14685887
[TBL] [Abstract][Full Text] [Related]
16. A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT.
Baum RP; Adams S; Kiefer J; Niesen A; Knecht R; Howaldt HP; Hertel A; Adamietz IA; Sykes T; Boniface GR
Acta Oncol; 1993; 32(7-8):747-51. PubMed ID: 8305222
[TBL] [Abstract][Full Text] [Related]
17. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Stuckensen T; Kovács AF; Adams S; Baum RP
J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
[TBL] [Abstract][Full Text] [Related]
18. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study.
van den Brekel MW; Castelijns JA; Stel HV; Golding RP; Meyer CJ; Snow GB
Eur Arch Otorhinolaryngol; 1993; 250(1):11-7. PubMed ID: 8466744
[TBL] [Abstract][Full Text] [Related]
19. Effect of reconstruction parameters in high-definition PET/CT on assessment of lymph node metastases in head and neck squamous cell carcinoma.
Sadick M; Molina F; Frey S; Piniol R; Sadick H; Brade J; Fink C; Schoenberg SO; He Y
J Nucl Med Technol; 2013 Mar; 41(1):19-25. PubMed ID: 23365259
[TBL] [Abstract][Full Text] [Related]
20. Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients.
Nieuwenhuis EJ; Colnot DR; Pijpers HJ; Castelijns JA; van Diest PJ; Brakenhoff RH; Snow GB; van den Brekel MW
Recent Results Cancer Res; 2000; 157():206-17. PubMed ID: 10857174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
